T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 7.5 USD 3.45% Market Closed
Market Cap: 374.7m USD

Intrinsic Value

The intrinsic value of one TLSI stock under the Base Case scenario is 4.1 USD. Compared to the current market price of 7.5 USD, TriSalus Life Sciences Inc is Overvalued by 45%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLSI Intrinsic Value
4.1 USD
Overvaluation 45%
Intrinsic Value
Price
T
Base Case Scenario

Valuation History
TriSalus Life Sciences Inc

What is Valuation History?
Ask AI Assistant
What other research platforms think about TLSI?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is TLSI valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for TriSalus Life Sciences Inc.

Explain Valuation
Compare TLSI to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TLSI?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
TriSalus Life Sciences Inc

Current Assets 33.3m
Cash & Short-Term Investments 22.7m
Receivables 5m
Other Current Assets 5.6m
Non-Current Assets 3.1m
PP&E 2.7m
Other Non-Current Assets 419k
Current Liabilities 10.9m
Accounts Payable 3.8m
Accrued Liabilities 6.9m
Other Current Liabilities 224k
Non-Current Liabilities 52.3m
Long-Term Debt 32.8m
Other Non-Current Liabilities 19.5m
Efficiency

Free Cash Flow Analysis
TriSalus Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
TriSalus Life Sciences Inc

Revenue
40.2m USD
Cost of Revenue
-6.4m USD
Gross Profit
33.8m USD
Operating Expenses
-65m USD
Operating Income
-31.3m USD
Other Expenses
-41m USD
Net Income
-72.3m USD
Fundamental Scores

TLSI Profitability Score
Profitability Due Diligence

TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Gross Margin
41/100
Profitability
Score

TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

TLSI Solvency Score
Solvency Due Diligence

TriSalus Life Sciences Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
37/100
Solvency
Score

TriSalus Life Sciences Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLSI Price Targets Summary
TriSalus Life Sciences Inc

Wall Street analysts forecast TLSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLSI is 11.58 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.

Lowest
Price Target
9.09 USD
21% Upside
Average
Price Target
11.58 USD
54% Upside
Highest
Price Target
16.8 USD
124% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

TriSalus Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TLSI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TLSI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TLSI stock?

The intrinsic value of one TLSI stock under the Base Case scenario is 4.1 USD.

Is TLSI stock undervalued or overvalued?

Compared to the current market price of 7.5 USD, TriSalus Life Sciences Inc is Overvalued by 45%.

Back to Top